Banner for leaf pages 2

Raltegravir (Isentress)

Also known as Isentress

Raltegravir (RAL, Isentress™, formerly MK-0518) is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.

Source: Wikipedia

Estimated Total Cost: $887.68 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed raltegravir to treat human immunodeficiency virus infection (hiv), viral hepatitis, rabies, and blastomycosis.

What drug interactions are known?

Do not take raltegravir if you are taking any of the following:

Critical Interactions

Significant Interactions

Ajax-loader Loading...